2024 | Targeted degradation of METTL3 against acute myeloid leukemia and gastric cancer | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2024 | Site-specific mutagenesis screening in KRASG12D mutant library to uncover resistance mechanisms to KRASG12D inhibitors | CANCER LETTERS |
2024 | A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout
| FRONTIERS IN IMMUNOLOGY |
2024 | Affinity‐Directed Site‐Specific Protein Labeling and Its Application to Antibody‐Drug Conjugates
| ADVANCED SCIENCE |
2023 | Synthesis and antibacterial activities of baulamycin A inspired derivatives | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2023 | Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase | CELL CHEMICAL BIOLOGY |
2023 | Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2023 | Identification of Thiazolo[5,4- b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance
| CANCERS |
2022 | Mapping the Degradable Kinome: A Resource for Expedited Degrader Development | MOLECULAR & CELLULAR PROTEOMICS |
2022 | Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug Resistance | JOURNAL OF MEDICINAL CHEMISTRY |
2022 | Identification of highly selective type II kinase inhibitors with chiral peptidomimetic tails | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY |
2022 | Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance | MOLECULAR CANCER THERAPEUTICS |
2022 | Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1 | JOURNAL OF MEDICINAL CHEMISTRY |
2022 | Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation | NEOPLASIA |
2021 | Novel Small Molecules Capable of Blocking mtRAS-Signaling Pathway
| FRONTIERS IN ONCOLOGY |
2021 | Anti-Tumor Activity of AZD4547 Against NTRK1 Fusion Positive Cancer Cells Through Inhibition of NTRKs
| FRONTIERS IN ONCOLOGY |
2021 | Synthesis and structure-activity relationships of targeted protein degraders for the understudied kinase NEK9 | Current Research in Chemical Biology |
2021 | Identification of Thieno[3,2- d]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3 | JOURNAL OF MEDICINAL CHEMISTRY |
2021 | Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug Resistance
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2021 | Natural and Synthetic Lactones Possessing Antitumor Activities
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2020 | Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development | CELL |
2020 | Anti-glioma effects of 2-aminothiophene-3-carboxamide derivatives, ANO1 channel blockers | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2020 | The first small molecules capable of strongly suppressing proliferation of cancer cells harboring BRAF class I/II/III mutations | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
2020 | Suppression of TRPM7 enhances TRAIL-induced apoptosis in triple-negative breast cancer cells | JOURNAL OF CELLULAR PHYSIOLOGY |
2020 | Two-photon probes for the endoplasmic reticulum: its detection in a live tissue by two-photon microscopy | CHEMICAL COMMUNICATIONS |